NRSN   $0.89  -3.26% Market Closed After Close 0.9 1.12%

Neurosense Therapeutics Ltd
Total Cash 1.21M
totalCashPerShare 0.067
EBITDA -11.69M
Total Debt 36.00K
quickRatio 0.452
currentRatio 0.462
Total Revenue
debtToEquity
Revenue/Share
ROA -1.50788
ROE
grossProfits
freeCashflow -6.63M
operatingCashflow -10.20M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 21.94M
forwardPE -2.3272727
floatShares 13.46M
sharesOutstanding 19.81M
sharesShort 235.72K
sharesShortPriorMonth 385.62K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.25%
heldPercentInstitutions 0.09%
Short Ratio help_outline 1.52%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.094
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -9.80M
trailingEps -0.65%
forwardEps -0.55%
enterpriseToEbitda -1.88
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 3Q 2024
institutionsCount 8
lastUpdated Nov. 7, 2024, 10:56 a.m.